Cell Source, Inc.
CLCS· OTC
Cell Source, Inc.
- Close
- Mar 25, 2026
- Market cap
- $34.23M
- 45.04M shares
- Filings
- 139
Price
Mar 25, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $1,938,173 | reported | |
| FY 2021 | 2021-12-31 | $1,273,352 | reported | |
| FY 2020 | 2020-12-31 | $834,943 | reported | |
| FY 2019 | 2019-12-31 | $2,457,051 | reported | |
| FY 2018 | 2018-12-31 | $274,937 | reported | |
| FY 2017 | 2017-12-31 | $637,318 | reported | |
| FY 2016 | 2016-12-31 | $554,185 | reported | |
| FY 2015 | 2015-12-31 | $392,925 | reported | |
| FY 2014 | 2014-12-31 | $806,157 | reported | |
| FY 2013 | 2013-12-31 | $351,513 | reported |
Cell Source, Inc. · CIK 1569340 · Engraved from SEC EDGAR
